Aliases & Classifications for Alopecia

MalaCards integrated aliases for Alopecia:

Name: Alopecia 12 74 58 29 6 43 15 71

Classifications:

Orphanet: 58  
Rare skin diseases


External Ids:

Disease Ontology 12 DOID:987
ICD9CM 34 704.0
MeSH 43 D000505
NCIt 49 C50575
SNOMED-CT 67 56317004
ICD10 32 L65.9
UMLS via Orphanet 72 C0002170
Orphanet 58 ORPHA79364
UMLS 71 C0002170

Summaries for Alopecia

Disease Ontology : 12 A hypotrichosis that is characterized by a loss of hair from the head or body.

MalaCards based summary : Alopecia is related to alopecia universalis congenita and alopecia-intellectual disability syndrome, and has symptoms including pruritus and exanthema. An important gene associated with Alopecia is SASH1 (SAM And SH3 Domain Containing 1). The drugs Acitretin and Hydroxychloroquine have been mentioned in the context of this disorder. Affiliated tissues include Hair, and related phenotypes are Decreased viability and Decreased viability

Wikipedia : 74 Hair loss, also known as alopecia or baldness, refers to a loss of hair from part of the head or body.... more...

Related Diseases for Alopecia

Diseases in the Alopecia family:

Alopecia, Congenital

Diseases related to Alopecia via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 1066, show less)
# Related Disease Score Top Affiliating Genes
1 alopecia universalis congenita 35.1 HR FOXN1 AIRE
2 alopecia-intellectual disability syndrome 34.6 LSS AHSG
3 alopecia-mental retardation syndrome 34.4 MBTPS2 LSS AHSG
4 atrichia with papular lesions 32.9 VDR HR ANTXR1
5 nail disorder, nonsyndromic congenital, 1 32.7 TP63 MBTPS2 AIRE
6 hypotrichosis 32.6 MBTPS2 LSS HR GJA1 DCAF17
7 hypotrichosis 11 32.3 RIN2 RBM28 DCAF17
8 telogen effluvium 31.7 VDR HR
9 keratosis 31.6 MBTPS2 GJA1 DSP
10 skin disease 31.3 VDR TP63 KRT14 GJA1 DSP
11 palmoplantar keratosis 30.9 SASH1 MBTPS2 GJA1 DSP
12 ectodermal dysplasia 30.9 TP63 KRT14 GJA1 DSP AIRE
13 familial woolly hair syndrome 30.7 MBTPS2 GJA1 DSP
14 pachyonychia congenita 1 30.6 MBTPS2 KRT14 DSP
15 hair disease 30.5 VDR MBTPS2 LSS KRT14 FOXN1 DSP
16 angular cheilitis 30.1 MBTPS2 AIRE
17 cardiomyopathy, dilated, with woolly hair and keratoderma 29.8 GJA1 DSP
18 alopecia areata 12.9
19 palmoplantar keratoderma and congenital alopecia 2 12.7
20 alopecia, androgenetic, 1 12.7
21 t-cell immunodeficiency, congenital alopecia, and nail dystrophy 12.7
22 androgenic alopecia 12.7
23 palmoplantar keratoderma and congenital alopecia 1 12.7
24 frontal fibrosing alopecia 12.6
25 alopecia totalis 12.6
26 mandibulofacial dysostosis with alopecia 12.6
27 alopecia, neurologic defects, and endocrinopathy syndrome 12.6
28 central centrifugal cicatricial alopecia 12.6
29 alopecia-mental retardation syndrome 1 12.5
30 alopecia, psychomotor epilepsy, pyorrhea, and mental subnormality 12.5
31 polyposis, skin pigmentation, alopecia, and fingernail changes 12.5
32 diffuse alopecia areata 12.5
33 alopecia-mental retardation syndrome 2 12.5
34 alopecia-contractures-dwarfism-intellectual disability syndrome 12.4
35 alopecia-contractures-dwarfism mental retardation syndrome 12.4
36 alopecia-mental retardation syndrome 4 12.4
37 ichthyosis, leukocyte vacuoles, alopecia, and sclerosing cholangitis 12.4
38 alopecia areata 1 12.4
39 alopecia, congenital 12.4
40 cancer, alopecia, pigment dyscrasia, onychodystrophy, and keratoderma 12.4
41 alopecia-epilepsy-oligophrenia syndrome of moynahan 12.3
42 odonto onycho dysplasia with alopecia 12.3
43 ichthyosis alopecia eclabion ectropion mental retardation 12.3
44 hypergonadotropic hypogonadism and partial alopecia 12.2
45 alopecia areata 2 12.2
46 alopecia, androgenetic, 2 12.2
47 alopecia intellectual disability syndrome 2 12.2
48 alopecia-mental retardation syndrome 3 12.2
49 alopecia universalis onychodystrophy vitiligo 12.2
50 woodhouse-sakati syndrome 12.2
51 alopecia-mental retardation syndrome with convulsions and hypergonadotropic hypogonadism 12.2
52 ichthyosis with alopecia, eclabium, ectropion, and mental retardation 12.2
53 genetic alopecia 12.1
54 alopecia, familial focal 12.1
55 alopecia universalis congenita, xy gonadal dysgenesis, and laryngomalacia 12.1
56 ifap syndrome with or without bresheck syndrome 12.1
57 gapo syndrome 12.1
58 thumb deformity and alopecia 12.1
59 alopecia, androgenetic, 3 12.1
60 cerebral arteriopathy, autosomal recessive, with subcortical infarcts and leukoencephalopathy 12.1
61 macs syndrome 12.1
62 ectodermal dysplasia alopecia preaxial polydactyly 12.1
63 thumb deformity, alopecia, pigmentation anomaly 12.1
64 follicular mucinosis 12.0
65 vitamin d-dependent rickets, type 2a 12.0
66 craniosynostosis alopecia brain defect 12.0
67 focal alopecia congenital megalencephaly 12.0
68 hypogonadism primary partial alopecia 12.0
69 alopecia antibody deficiency 12.0
70 hypogonadotropic hypogonadism-frontoparietal alopecia syndrome 12.0
71 global developmental delay-alopecia-macrocephaly-facial dysmorphism-structural brain anomalies syndrome 12.0
72 johnson neuroectodermal syndrome 12.0
73 satoyoshi syndrome 11.9
74 gomez-lopez-hernandez syndrome 11.9
75 parc syndrome 11.9
76 hypotrichosis 7 11.9
77 pseudopelade of brocq 11.8
78 crandall syndrome 11.8
79 lipedematous scalp 11.8
80 frontonasal dysplasia 2 11.8
81 moloney syndrome 11.6
82 dermatopathia pigmentosa reticularis 11.6
83 quinquaud folliculitis decalvans 11.6
84 monilethrix 11.6
85 marie unna congenital hypotrichosis 11.6
86 biotinidase deficiency 11.6
87 clouston syndrome 11.6
88 rickets 11.5
89 trichotillomania 11.5
90 acrodermatitis enteropathica, zinc-deficiency type 11.5
91 encephalocraniocutaneous lipomatosis 11.5
92 graham-little-piccardi-lassueur syndrome 11.4
93 autoimmune polyendocrine syndrome, type i, with or without reversible metaphyseal dysplasia 11.4
94 palmoplantar keratoderma, mutilating, with periorificial keratotic plaques 11.4
95 autoimmune polyglandular syndrome type 3 11.4
96 hutchinson-gilford progeria syndrome 11.4
97 palmoplantar keratoderma, mutilating, with periorificial keratotic plaques, x-linked 11.4
98 reticulate acropigmentation of kitamura 11.4
99 dermatitis, atopic 11.4
100 lupus erythematosus 11.4
101 trichoscyphodysplasia 11.3
102 systemic lupus erythematosus 11.3
103 keratosis follicularis spinulosa decalvans 11.3
104 loose anagen hair syndrome 11.3
105 perifolliculitis capitis abscedens et suffodiens, familial 11.3
106 incontinentia pigmenti 11.3
107 aplasia cutis congenita, nonsyndromic 11.3
108 chronic mucocutaneous candidiasis 11.3
109 pityriasis rubra pilaris 11.3
110 vogt-koyanagi-harada disease 11.3
111 hypotrichosis simplex 11.3
112 keratosis follicularis spinulosa decalvans, autosomal dominant 11.3
113 autosomal recessive congenital ichthyosis 11.3
114 lepromatous leprosy 11.3
115 multiple carboxylase deficiency 11.3
116 stevens-johnson syndrome/toxic epidermal necrolysis 11.3
117 hemifacial atrophy, progressive 11.3
118 nevus, epidermal 11.3
119 hypervitaminosis a 11.3
120 lipoid proteinosis of urbach and wiethe 11.3
121 mitochondrial complex iii deficiency, nuclear type 10 11.3
122 tinea favosa 11.3
123 sezary's disease 11.3
124 trichothiodystrophy 11.3
125 omenn syndrome 11.2
126 metaphyseal chondrodysplasia with cone-shaped epiphyses, normal hair, and normal hands 11.2
127 slti salem syndrome 11.2
128 zinc deficiency, transient neonatal 11.2
129 adult syndrome 11.1
130 hypotrichosis 4 11.1
131 mucoepithelial dysplasia, hereditary 11.1
132 ectodermal dysplasia 4, hair/nail type 11.1
133 ectodermal dysplasia/skin fragility syndrome 11.1
134 skin fragility-woolly hair syndrome 11.1
135 epidermolysis bullosa, lethal acantholytic 11.1
136 hypotrichosis 5 11.1
137 cutaneous telangiectasia and cancer syndrome, familial 11.1
138 ichthyosis, congenital, autosomal recessive 9 11.1
139 naegeli-franceschetti-jadassohn syndrome/dermatopathia pigmentosa reticularis 11.1
140 tetramelic deficiencies, ectodermal dysplasia, deformed ears, and other abnormalities 11.0
141 noonan syndrome with multiple lentigines 11.0
142 garret tripp syndrome 11.0
143 ankyloblepharon-ectodermal defects-cleft lip/palate 10.9
144 frontonasal dysplasia 1 10.9
145 ichthyosis bullosa of siemens 10.9
146 ectodermal dysplasia, hypohidrotic, with hypothyroidism and ciliary dyskinesia 10.9
147 ichthyosis, congenital, autosomal recessive 2 10.9
148 ichthyosis, congenital, autosomal recessive 1 10.9
149 mandibuloacral dysplasia with type a lipodystrophy 10.9
150 metaphyseal acroscyphodysplasia 10.9
151 holocarboxylase synthetase deficiency 10.9
152 hypotrichosis 8 10.9
153 mental retardation, x-linked, syndromic, claes-jensen type 10.9
154 chondrodysplasia punctata 2, x-linked dominant 10.9
155 immunodysregulation, polyendocrinopathy, and enteropathy, x-linked 10.9
156 keratosis follicularis spinulosa decalvans, x-linked 10.9
157 keratosis follicularis, dwarfism, and cerebral atrophy 10.9
158 vitamin d-dependent rickets, type 2b, with normal vitamin d receptor 10.9
159 ichthyosis, congenital, autosomal recessive 4a 10.9
160 ichthyosis, congenital, autosomal recessive 11 10.9
161 poikiloderma with neutropenia 10.9
162 ichthyosis, congenital, autosomal recessive 5 10.9
163 hypotrichosis 1 10.9
164 ichthyosis, congenital, autosomal recessive 3 10.9
165 hypotrichosis 6 10.9
166 ichthyosis, congenital, autosomal recessive 6 10.9
167 ichthyosis, congenital, autosomal recessive 8 10.9
168 nestor-guillermo progeria syndrome 10.9
169 ichthyosis, congenital, autosomal recessive 7 10.9
170 ichthyosis, congenital, autosomal recessive 10 10.9
171 t-cell receptor-alpha/beta deficiency 10.9
172 epidermolysis bullosa simplex, generalized, with scarring and hair loss 10.9
173 hyper-ige recurrent infection syndrome 3, autosomal recessive 10.9
174 ectodermal dysplasia with facial dysmorphism and acral, ocular, and brain anomalies 10.9
175 junctional epidermolysis bullosa 10.9
176 epidermolysis bullosa with pyloric atresia 10.9
177 pnpla6-related disorders 10.9
178 aniridia - ptosis - intellectual disability - familial obesity 10.9
179 bier spots 10.9
180 bullous dystrophy hereditary macular type 10.9
181 fetal minoxidil syndrome 10.9
182 ulerythema ophryogenesis 10.9
183 autoimmune disease 10.9
184 vitiligo-associated multiple autoimmune disease susceptibility 6 10.7
185 vitiligo-associated multiple autoimmune disease susceptibility 1 10.7
186 psoriasis 10.6
187 pustulosis of palm and sole 10.6
188 lichen planus 10.6
189 rapidly involuting congenital hemangioma 10.6
190 alpha/beta t-cell lymphopenia with gamma/delta t-cell expansion, severe cytomegalovirus infection, and autoimmunity 10.6
191 dermatitis 10.6
192 folliculitis 10.6
193 oncocytic breast carcinoma 10.5 KRT14 AR
194 ige responsiveness, atopic 10.5
195 neurofibromatosis, type ii 10.5
196 discoid lupus erythematosus 10.5
197 ameloblastic carcinoma 10.5 TP63 KRT14
198 hypothyroidism 10.5
199 striate palmoplantar keratoderma 10.5 KRT14 DSP
200 lipoadenoma 10.5 TP63 KRT14
201 limbal stem cell deficiency 10.5 TP63 KRT14 GJA1
202 eccrine papillary adenocarcinoma 10.5 KRT14 AHSG
203 contact dermatitis 10.5
204 pinguecula 10.5 TP63 KRT14
205 ichthyosis 10.5
206 breast fibroadenoma 10.5 TP63 KRT14 AR
207 dermatophytosis 10.4
208 apocrine sweat gland neoplasm 10.4 KRT14 AR
209 pleomorphic adenoma 10.4 TP63 KRT14 AR
210 thyroiditis 10.4
211 gingival hypertrophy 10.4 RIN2 ANTXR1
212 syphilis 10.4
213 tinea capitis 10.4
214 calciphylaxis 10.4 VDR AHSG
215 dowling-degos disease 1 10.4
216 cystic basal cell carcinoma 10.4 TP63 KRT14
217 atrophoderma vermiculata 10.4
218 mycosis fungoides 10.3
219 hypogonadism 10.3
220 sarcoidosis 1 10.3
221 impotence 10.3
222 hyperandrogenism 10.3
223 hypertrichosis 10.3
224 secondary syphilis 10.3
225 intraductal papilloma 10.3 TP63 KRT14
226 hashimoto thyroiditis 10.3
227 prostatic hypertrophy 10.3
228 seborrheic dermatitis 10.3
229 crohn's disease 10.3
230 cytokine deficiency 10.3
231 myasthenia gravis 10.2
232 prostatic hyperplasia, benign 10.2
233 cutaneous lupus erythematosus 10.2
234 prostatic adenoma 10.2
235 allergic contact dermatitis 10.2
236 cellulitis 10.2
237 down syndrome 10.2
238 sexual disorder 10.2
239 anhidrosis 10.2
240 anxiety 10.2
241 diarrhea 10.2
242 severe combined immunodeficiency 10.2
243 lichen planus pigmentosus 10.2
244 hereditary hypophosphatemic rickets 10.2
245 darier-white disease 10.2
246 exanthem 10.2
247 polycystic ovary syndrome 10.2
248 hypotrichosis, congenital, with juvenile macular dystrophy 10.2
249 rare lichen planus 10.2
250 rare cutaneous lichen planus 10.2
251 breast cancer 10.2
252 autosomal recessive disease 10.2
253 panniculitis 10.2
254 systemic scleroderma 10.2
255 pemphigus 10.2
256 immune deficiency disease 10.2
257 branchiootic syndrome 1 10.2
258 inflammatory bowel disease 10.2
259 lymphoma 10.2
260 uveitis 10.2
261 candidiasis 10.2
262 urticaria 10.2
263 epidermolysis bullosa 10.2
264 rhinitis 10.2
265 chronic cutaneous lupus erythematosus 10.2
266 hair whorl 10.2
267 thymoma, familial 10.2
268 graft-versus-host disease 10.2
269 syringoma 10.2
270 thymoma 10.2
271 thyroid gland disease 10.2
272 cataract 10.2
273 ulcerative colitis 10.2
274 vasculitis 10.1
275 rosacea 10.1
276 celiac disease 1 10.1
277 allergic rhinitis 10.1
278 microcephaly 10.1
279 hyperparathyroidism 10.1
280 iron metabolism disease 10.1
281 bullous pemphigoid 10.1
282 47,xyy 10.1
283 leprosy 3 10.1
284 3-methylglutaconic aciduria, type iii 10.1
285 psoriatic arthritis 10.1
286 porphyria 10.1
287 skin atrophy 10.1
288 hansen's disease 10.1
289 retinal dystrophy, iris coloboma, and comedogenic acne syndrome 10.1
290 alexithymia 10.1
291 lipid metabolism disorder 10.1
292 parapsoriasis 10.1
293 amyloidosis 10.1
294 48,xyyy 10.1
295 depression 10.1
296 pemphigus vulgaris, familial 10.1
297 porphyria cutanea tarda 10.1
298 ringed hair 10.1
299 cutaneous t cell lymphoma 10.1
300 allergic hypersensitivity disease 10.1
301 graves' disease 10.1
302 localized scleroderma 10.1
303 diabetes mellitus 10.1
304 chronic graft versus host disease 10.1
305 erythrokeratoderma ''en cocardes'' 10.1
306 phacomatosis pigmentovascularis 10.1
307 headache 10.1
308 lichen sclerosus et atrophicus 10.0
309 prostate cancer 10.0
310 rheumatoid arthritis 10.0
311 congenital heart defects, hamartomas of tongue, and polysyndactyly 10.0
312 ataxia, combined cerebellar and peripheral, with hearing loss and diabetes mellitus 10.0
313 deficiency anemia 10.0
314 hypophosphatemia 10.0
315 colitis 10.0
316 arteriovenous malformation 10.0
317 goiter 10.0
318 neutropenia 10.0
319 mental depression 10.0
320 pemphigus foliaceus 10.0
321 arteries, anomalies of 10.0
322 pernicious anemia 10.0
323 lipoid congenital adrenal hyperplasia 10.0
324 lung cancer 10.0
325 anemia, x-linked, with or without neutropenia and/or platelet abnormalities 10.0
326 body mass index quantitative trait locus 1 10.0
327 hyperlipoproteinemia, type iii 10.0
328 lipoprotein quantitative trait locus 10.0
329 sensorineural hearing loss 10.0
330 hypoparathyroidism 10.0
331 secondary hyperparathyroidism 10.0
332 gonadal dysgenesis 10.0
333 thrombocytopenia 10.0
334 agammaglobulinemia 10.0
335 neurodermatitis 10.0
336 hyperthyroidism 10.0
337 polyendocrinopathy 10.0
338 breast ductal carcinoma 10.0 TP63 KRT14 AR
339 obsessive-compulsive disorder 10.0
340 trichomegaly 10.0
341 multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephaly 10.0
342 mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndrome 10.0
343 alacrima, achalasia, and mental retardation syndrome 10.0
344 hyperprolactinemia 10.0
345 ptosis 10.0
346 covid-19 10.0
347 dermatomyositis 10.0
348 social phobia 10.0
349 heart disease 10.0
350 infant gynecomastia 10.0
351 gynecomastia 10.0
352 telangiectasis 10.0
353 amenorrhea 10.0
354 autoimmune polyendocrine syndrome 10.0
355 hepatitis c 10.0
356 dysostosis 10.0
357 irritant dermatitis 10.0
358 pyoderma 10.0
359 myopathy 10.0
360 liver cirrhosis 10.0
361 neurofibromatosis 10.0
362 hypereosinophilic syndrome 10.0
363 al amyloidosis 10.0
364 oral lichen planus 10.0
365 pili torti 10.0
366 encephalopathy 10.0
367 posttransplant acute limbic encephalitis 10.0
368 fibrosis of extraocular muscles, congenital, 1 9.9
369 myositis 9.9
370 osteoporosis 9.9
371 ocular motor apraxia 9.9
372 retinitis pigmentosa 9.9
373 insulin-like growth factor i 9.9
374 hypocalcemia, autosomal dominant 1 9.9
375 coronary heart disease 1 9.9
376 major depressive disorder 9.9
377 hepatitis c virus 9.9
378 bone mineral density quantitative trait locus 8 9.9
379 bone mineral density quantitative trait locus 15 9.9
380 scoliosis 9.9
381 bone disease 9.9
382 urolithiasis 9.9
383 neuroretinitis 9.9
384 tonsillitis 9.9
385 osteomalacia 9.9
386 cicatricial pemphigoid 9.9
387 nephrotic syndrome 9.9
388 common variable immunodeficiency 9.9
389 paronychia 9.9
390 skin sarcoidosis 9.9
391 polyneuropathy 9.9
392 generalized anxiety disorder 9.9
393 disease of mental health 9.9
394 personality disorder 9.9
395 leiomyosarcoma 9.9
396 spondylosis 9.9
397 basal cell carcinoma 9.9
398 relapsing polychondritis 9.9
399 purpura 9.9
400 turner syndrome 9.9
401 mastocytosis 9.9
402 retinitis 9.9
403 gastric adenocarcinoma 9.9
404 epidermolysis bullosa simplex 9.9
405 lymphopenia 9.9
406 impetigo 9.9
407 herpes zoster 9.9
408 neuropathy 9.9
409 cholangitis 9.9
410 adverse events of 5-alpha-reductase inhibitors 9.9
411 dwarfism 9.9
412 growth hormone deficiency 9.9
413 homologous wasting disease 9.9
414 aneurysm 9.9
415 cerebral aneurysms 9.9
416 overgrowth syndrome 9.9
417 alcohol dependence 9.8
418 spondyloarthropathy 1 9.8
419 atrial standstill 1 9.8
420 cleft palate, isolated 9.8
421 coloboma of macula 9.8
422 keratitis, hereditary 9.8
423 meralgia paraesthetica, familial 9.8
424 scleroderma, familial progressive 9.8
425 small cell cancer of the lung 9.8
426 temporal arteritis 9.8
427 adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency 9.8
428 lymphoma, hodgkin, classic 9.8
429 myeloma, multiple 9.8
430 myxedema 9.8
431 pancreatic cancer 9.8
432 hypophosphatemic rickets, x-linked recessive 9.8
433 aging 9.8
434 helicobacter pylori infection 9.8
435 human immunodeficiency virus type 1 9.8
436 melanoma, cutaneous malignant 10 9.8
437 angiosarcoma 9.8
438 superficial mycosis 9.8
439 erythema multiforme 9.8
440 hypogonadotropic hypogonadism 9.8
441 tetanus 9.8
442 iron deficiency anemia 9.8
443 visual epilepsy 9.8
444 inflammatory spondylopathy 9.8
445 male infertility 9.8
446 pancytopenia 9.8
447 anodontia 9.8
448 sclerosing cholangitis 9.8
449 angioedema 9.8
450 neuritis 9.8
451 epilepsy 9.8
452 melanoma 9.8
453 autoimmune hepatitis 9.8
454 arteriosclerosis 9.8
455 adenocarcinoma 9.8
456 mood disorder 9.8
457 gastritis 9.8
458 epidermolysis bullosa acquisita 9.8
459 conjunctivitis 9.8
460 connective tissue disease 9.8
461 spondylitis 9.8
462 cerebrovascular disease 9.8
463 narcolepsy 9.8
464 encephalitis 9.8
465 muscular dystrophy 9.8
466 keloid disorder 9.8
467 hidrotic ectodermal dysplasia 2 9.8
468 drug reaction with eosinophilia and systemic symptoms 9.8
469 ichthyosis, follicular 9.8
470 linear scleroderma 9.8
471 raynaud phenomenon 9.8
472 cytomegalovirus infection 9.8
473 paraneoplastic syndromes 9.8
474 seizure disorder 9.8
475 folliculotropic mycosis fungoides 9.8
476 pik3ca-related overgrowth syndrome 9.8
477 rare genetic skin disease 9.8
478 thyroid carcinoma 9.8
479 acrocephalopolysyndactyly type iii 9.8
480 pfeiffer syndrome 9.8
481 arteriovenous malformations of the brain 9.8
482 atherosclerosis susceptibility 9.8
483 hepatocellular carcinoma 9.8
484 vohwinkel syndrome 9.8
485 cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1 9.8
486 multiple sclerosis 9.8
487 epidermoid cysts 9.8
488 pilomatrixoma 9.8
489 hypotrichosis-lymphedema-telangiectasia-renal defect syndrome 9.8
490 chromosome 18p deletion syndrome 9.8
491 ichthyosis vulgaris 9.8
492 laryngomalacia 9.8
493 medulloblastoma 9.8
494 migraine with or without aura 1 9.8
495 buschke-ollendorff syndrome 9.8
496 ovarian cancer 9.8
497 retinal detachment 9.8
498 steatocystoma multiplex 9.8
499 sturge-weber syndrome 9.8
500 chromosome 2q35 duplication syndrome 9.8
501 thrombocytopenic purpura, autoimmune 9.8
502 cryptorchidism, unilateral or bilateral 9.8
503 diabetes mellitus, type i 9.8
504 ectodermal dysplasia 10b, hypohidrotic/hair/tooth type, autosomal recessive 9.8
505 epidermolysis bullosa simplex with muscular dystrophy 9.8
506 halo nevi 9.8
507 hemochromatosis, type 1 9.8
508 bjornstad syndrome 9.8
509 rothmund-thomson syndrome, type 2 9.8
510 body mass index quantitative trait locus 11 9.8
511 deafness-hypogonadism syndrome 9.8
512 focal dermal hypoplasia 9.8
513 ataxia and polyneuropathy, adult-onset 9.8
514 dermatitis herpetiformis, familial 9.8
515 yemenite deaf-blind hypopigmentation syndrome 9.8
516 body mass index quantitative trait locus 9 9.8
517 body mass index quantitative trait locus 8 9.8
518 anorexia nervosa 9.8
519 body mass index quantitative trait locus 4 9.8
520 body mass index quantitative trait locus 10 9.8
521 leukemia, chronic myeloid 9.8
522 body mass index quantitative trait locus 7 9.8
523 aplastic anemia 9.8
524 intraocular pressure quantitative trait locus 9.8
525 body mass index quantitative trait locus 12 9.8
526 body mass index quantitative trait locus 14 9.8
527 cholangitis, primary sclerosing 9.8
528 lipedema 9.8
529 nail disorder, nonsyndromic congenital, 9 9.8
530 pulmonary fibrosis and/or bone marrow failure, telomere-related, 2 9.8
531 body mass index quantitative trait locus 18 9.8
532 cholangiocarcinoma 9.8
533 joint laxity, short stature, and myopia 9.8
534 helix syndrome 9.8
535 body mass index quantitative trait locus 19 9.8
536 t-cell lymphoma, subcutaneous panniculitis-like 9.8
537 body mass index quantitative trait locus 20 9.8
538 juvenile arthritis 9.8
539 t-cell lymphopenia, infantile, with or without nail dystrophy, autosomal dominant 9.8
540 autoimmune polyendocrine syndrome type 1 9.8
541 adult t-cell leukemia 9.8
542 crohn's colitis 9.8
543 pollen allergy 9.8
544 thrombosis 9.8
545 hereditary lymphedema i 9.8
546 x-linked chondrodysplasia punctata 2 9.8
547 igg4-related disease 9.8
548 neurodegeneration with brain iron accumulation 9.8
549 cholelithiasis 9.8
550 tuberculoid leprosy 9.8
551 bacterial infectious disease 9.8
552 intracranial aneurysm 9.8
553 ovarian disease 9.8
554 rabies 9.8
555 myopia 9.8
556 conn's syndrome 9.8
557 leukemia 9.8
558 pseudobulbar palsy 9.8
559 gout 9.8
560 cutaneous porphyria 9.8
561 coccidioidomycosis 9.8
562 poems syndrome 9.8
563 toxic shock syndrome 9.8
564 estrogen excess 9.8
565 avoidant personality disorder 9.8
566 cystitis 9.8
567 facial hemiatrophy 9.8
568 vascular disease 9.8
569 hyperuricemia 9.8
570 amelogenesis imperfecta 9.8
571 hepatitis 9.8
572 relapsing-remitting multiple sclerosis 9.8
573 acrodermatitis 9.8
574 food allergy 9.8
575 scalp dermatosis 9.8
576 scleredema adultorum 9.8
577 mammary paget's disease 9.8
578 skin carcinoma 9.8
579 necrobiosis lipoidica 9.8
580 pseudohermaphroditism 9.8
581 granuloma annulare 9.8
582 arthropathy 9.8
583 adrenal carcinoma 9.8
584 trophoblastic neoplasm 9.8
585 hyperglycemia 9.8
586 prostate disease 9.8
587 somatoform disorder 9.8
588 intrahepatic cholangiocarcinoma 9.8
589 ovarian cyst 9.8
590 chronic inflammatory demyelinating polyradiculoneuropathy 9.8
591 infertility 9.8
592 intestinal disease 9.8
593 hemolytic anemia 9.8
594 bronchitis 9.8
595 acquired immunodeficiency syndrome 9.8
596 plasma cell neoplasm 9.8
597 juvenile rheumatoid arthritis 9.8
598 b-cell lymphoma 9.8
599 t-cell lymphoblastic leukemia/lymphoma 9.8
600 chronic kidney disease 9.8
601 retinal degeneration 9.8
602 dermatitis herpetiformis 9.8
603 pyoderma gangrenosum 9.8
604 herpes simplex 9.8
605 myeloid leukemia 9.8
606 atrophic gastritis 9.8
607 pityriasis versicolor 9.8
608 cleft lip 9.8
609 keratoconjunctivitis 9.8
610 hypopituitarism 9.8
611 blepharitis 9.8
612 refractive error 9.8
613 htra1 disorder 9.8
614 cutis verticis gyrata 9.8
615 erosive pustular dermatosis of the scalp 9.8
616 granulocytopenia 9.8
617 halo nevus 9.8
618 ichthyosis, acquired 9.8
619 leukemia, t-cell, chronic 9.8
620 lupus erythematosus tumidus 9.8
621 lymphosarcoma 9.8
622 pseudoainhum 9.8
623 trichostasis spinulosa 9.8
624 weber syndrome 9.8
625 paresthesia 9.8
626 progeroid syndrome 9.8
627 ring chromosome 9.8
628 lupus erythematosus panniculitis 9.8
629 microtia 9.8
630 intestinal polyposis syndrome 9.8
631 acanthosis nigricans 9.6
632 ainhum 9.6
633 amyotrophic lateral sclerosis 1 9.6
634 gastroesophageal reflux 9.6
635 basal cell nevus syndrome 9.6
636 bladder cancer 9.6
637 blepharophimosis, ptosis, and epicanthus inversus 9.6
638 epidermolytic hyperkeratosis 9.6
639 cone-rod dystrophy 2 9.6
640 epicanthus 9.6
641 epidermolysis bullosa simplex with mottled pigmentation 9.6
642 esophageal cancer 9.6
643 glomuvenous malformations 9.6
644 attention deficit-hyperactivity disorder 9.6
645 hypercholesterolemia, familial, 1 9.6
646 renal cell carcinoma, nonpapillary 9.6
647 hypertelorism 9.6
648 hypertension, essential 9.6
649 hypotrichosis 2 9.6
650 kaposi sarcoma 9.6
651 klippel-trenaunay-weber syndrome 9.6
652 lentigines 9.6
653 lipomatosis, multiple 9.6
654 lymphatic malformation 5 9.6
655 mastocytosis, cutaneous 9.6
656 meniere disease 9.6
657 nevus anemicus 9.6
658 noonan syndrome 1 9.6
659 ocular cicatricial pemphigoid 9.6
660 hemifacial microsomia 9.6
661 papillomatosis, confluent and reticulated 9.6
662 pectus excavatum 9.6
663 polycystic liver disease 1 with or without kidney cysts 9.6
664 porphyria, acute intermittent 9.6
665 pseudo-von willebrand disease 9.6
666 keratosis, seborrheic 9.6
667 split-hand/foot malformation 1 9.6
668 strabismus 9.6
669 thrombophilia due to thrombin defect 9.6
670 triiodothyronine receptor auxiliary protein 9.6
671 suppressor of tumorigenicity 3 9.6
672 uncombable hair syndrome 1 9.6
673 varicose veins 9.6
674 widow's peak 9.6
675 anemia, autoimmune hemolytic 9.6
676 takayasu arteritis 9.6
677 argininosuccinic aciduria 9.6
678 cystic fibrosis 9.6
679 dandy-walker syndrome 9.6
680 ectodermal dysplasia, ectrodactyly, and macular dystrophy syndrome 9.6
681 galactorrhea 9.6
682 heart block, congenital 9.6
683 holoprosencephaly 1 9.6
684 hydrocephalus, congenital, 1 9.6
685 hypoadrenocorticism, familial 9.6
686 hypoascorbemia 9.6
687 gastrointestinal defects and immunodeficiency syndrome 9.6
688 cartilage-hair hypoplasia 9.6
689 moyamoya disease 1 9.6
690 netherton syndrome 9.6
691 laron syndrome 9.6
692 pseudoxanthoma elasticum 9.6
693 sjogren-larsson syndrome 9.6
694 testicular germ cell tumor 9.6
695 squamous cell carcinoma, head and neck 9.6
696 oliver-mcfarlane syndrome 9.6
697 mayer-rokitansky-kuster-hauser syndrome 9.6
698 xeroderma pigmentosum, variant type 9.6
699 adrenoleukodystrophy 9.6
700 hypomelanosis of ito 9.6
701 bazex syndrome 9.6
702 aicardi syndrome 9.6
703 orofaciodigital syndrome i 9.6
704 androgen insensitivity, partial 9.6
705 spinal and bulbar muscular atrophy, x-linked 1 9.6
706 gonadoblastoma 9.6
707 oculoectodermal syndrome 9.6
708 frontotemporal dementia 9.6
709 aplasia cutis congenita, high myopia, and cone-rod dysfunction 9.6
710 naxos disease 9.6
711 neurofibromatosis-noonan syndrome 9.6
712 arthrogryposis and ectodermal dysplasia 9.6
713 macular degeneration, age-related, 1 9.6
714 brittle bone disorder 9.6
715 cervical cancer 9.6
716 panbronchiolitis, diffuse 9.6
717 langerhans cell histiocytosis 9.6
718 systemic lupus erythematosus 3 9.6
719 psoriasis 7 9.6
720 alveolar soft part sarcoma 9.6
721 gastrointestinal stromal tumor 9.6
722 neutrophilic dermatosis, acute febrile 9.6
723 endometrial cancer 9.6
724 myocardial infarction 9.6
725 legionnaire disease 9.6
726 severe cutaneous adverse reaction 9.6
727 autoimmune disease 4 9.6
728 esophagitis, eosinophilic, 1 9.6
729 cone-rod synaptic disorder, congenital nonprogressive 9.6
730 kawasaki disease 9.6
731 diabetes mellitus, ketosis-prone 9.6
732 pseudofolliculitis barbae 9.6
733 major affective disorder 8 9.6
734 major affective disorder 9 9.6
735 leukemia, acute lymphoblastic 9.6
736 gastric cancer 9.6
737 psoriasis 14, pustular 9.6
738 membranous nephropathy 9.6
739 leptin deficiency or dysfunction 9.6
740 immunodeficiency, common variable, 10 9.6
741 poikiloderma, hereditary fibrosing, with tendon contractures, myopathy, and pulmonary fibrosis 9.6
742 seizures, scoliosis, and macrocephaly/microcephaly syndrome 9.6
743 spastic paraplegia, intellectual disability, nystagmus, and obesity 9.6
744 squalene synthase deficiency 9.6
745 encephalopathy, progressive, early-onset, with episodic rhabdomyolysis 9.6
746 gastrointestinal ulceration, recurrent, with dysfunctional platelets 9.6
747 chronic ulcer of skin 9.6
748 autoimmune pancreatitis 9.6
749 tick-borne encephalitis 9.6
750 arrhythmogenic right ventricular cardiomyopathy 9.6
751 early congenital syphilis 9.6
752 o'nyong'nyong fever 9.6
753 hereditary lymphedema 9.6
754 vitamin b12 deficiency 9.6
755 diffuse large b-cell lymphoma 9.6
756 metabolic acidosis 9.6
757 primary progressive multiple sclerosis 9.6
758 biotin deficiency 9.6
759 oromandibular dystonia 9.6
760 hemorrhagic cystitis 9.6
761 immunoglobulin alpha deficiency 9.6
762 ductal carcinoma in situ 9.6
763 cardiac arrest 9.6
764 inguinal hernia 9.6
765 umbilical hernia 9.6
766 ectopic pregnancy 9.6
767 acrodermatitis chronica atrophicans 9.6
768 drug allergy 9.6
769 metal allergy 9.6
770 salmonellosis 9.6
771 cerebellar hypoplasia 9.6
772 fibrous dysplasia 9.6
773 cutaneous candidiasis 9.6
774 hepatic veno-occlusive disease 9.6
775 mitochondrial complex iii deficiency 9.6
776 asymptomatic neurosyphilis 9.6
777 pigmentation disease 9.6
778 keratoconus 9.6
779 psychosexual disorder 9.6
780 osteonecrosis 9.6
781 osteomyelitis 9.6
782 pleomorphic lipoma 9.6
783 mumps 9.6
784 monocular esotropia 9.6
785 blepharophimosis 9.6
786 nasopharyngitis 9.6
787 esophageal atresia 9.6
788 leukodystrophy 9.6
789 glucose intolerance 9.6
790 protein-losing enteropathy 9.6
791 allergic urticaria 9.6
792 microphthalmia 9.6
793 open-angle glaucoma 9.6
794 chronic frontal sinusitis 9.6
795 frontal sinusitis 9.6
796 meningocele 9.6
797 hydrocephalus 9.6
798 amnestic disorder 9.6
799 obsessive-compulsive personality disorder 9.6
800 pasteurellosis 9.6
801 brucellosis 9.6
802 hydronephrosis 9.6
803 pertussis 9.6
804 anogenital venereal wart 9.6
805 t cell deficiency 9.6
806 primary hyperparathyroidism 9.6
807 allergic conjunctivitis 9.6
808 megacolon 9.6
809 diphtheria 9.6
810 horner's syndrome 9.6
811 retinal vasculitis 9.6
812 listeriosis 9.6
813 dysgammaglobulinemia 9.6
814 esophagitis 9.6
815 hypertrophic cardiomyopathy 9.6
816 sympathetic ophthalmia 9.6
817 cryptococcosis 9.6
818 optic neuritis 9.6
819 hemosiderosis 9.6
820 dysthymic disorder 9.6
821 otosclerosis 9.6
822 dengue disease 9.6
823 primary biliary cirrhosis 9.6
824 tinea pedis 9.6
825 von willebrand's disease 9.6
826 hemolytic-uremic syndrome 9.6
827 blastomycosis 9.6
828 intermediate uveitis 9.6
829 lagophthalmos 9.6
830 tinea unguium 9.6
831 brain cancer 9.6
832 nodular goiter 9.6
833 endemic goiter 9.6
834 congenital dyserythropoietic anemia 9.6
835 pure red-cell aplasia 9.6
836 pulmonary sarcoidosis 9.6
837 achromatopsia 9.6
838 benign paroxysmal positional nystagmus 9.6
839 iritis 9.6
840 acute retrobulbar neuritis 9.6
841 acute thyroiditis 9.6
842 corneal ectasia 9.6
843 sporotrichosis 9.6
844 glossitis 9.6
845 papilledema 9.6
846 fungal infectious disease 9.6
847 ectropion 9.6
848 alcohol use disorder 9.6
849 thrombocytopenia due to platelet alloimmunization 9.6
850 lymphadenitis 9.6
851 histoplasmosis 9.6
852 squamous cell carcinoma 9.6
853 cheilitis 9.6
854 calcinosis 9.6
855 viral hepatitis 9.6
856 optic nerve disease 9.6
857 cerebral palsy 9.6
858 neuroma 9.6
859 exostosis 9.6
860 enthesopathy 9.6
861 post-traumatic stress disorder 9.6
862 constipation 9.6
863 b cell deficiency 9.6
864 tularemia 9.6
865 dental caries 9.6
866 essential thrombocythemia 9.6
867 hidradenitis suppurativa 9.6
868 hidradenitis 9.6
869 keratopathy 9.6
870 lateral sclerosis 9.6
871 colon adenocarcinoma 9.6
872 craniosynostosis 9.6
873 gangliocytoma 9.6
874 retinal vascular disease 9.6
875 testicular disease 9.6
876 corneal dystrophy 9.6
877 kidney cancer 9.6
878 leydig cell tumor 9.6
879 phimosis 9.6
880 endometriosis 9.6
881 acute pancreatitis 9.6
882 glomerulonephritis 9.6
883 bronchiolitis 9.6
884 pulmonary tuberculosis 9.6
885 acute kidney failure 9.6
886 gingivitis 9.6
887 mucinoses 9.6
888 cutis laxa 9.6
889 lipomatosis 9.6
890 complex regional pain syndrome 9.6
891 rhabdomyosarcoma 9.6
892 thymic carcinoma 9.6
893 bipolar disorder 9.6
894 fibrosarcoma 9.6
895 inappropriate adh syndrome 9.6
896 histiocytosis 9.6
897 breast adenocarcinoma 9.6
898 breast disease 9.6
899 sertoli cell tumor 9.6
900 placental site trophoblastic tumor 9.6
901 lactic acidosis 9.6
902 mast cell neoplasm 9.6
903 plasmacytoma 9.6
904 pulmonary fibrosis 9.6
905 pleural empyema 9.6
906 insulinoma 9.6
907 pancreatic adenocarcinoma 9.6
908 nail disease 9.6
909 pseudohypoparathyroidism 9.6
910 glucose metabolism disease 9.6
911 polyradiculoneuropathy 9.6
912 seminoma 9.6
913 orofaciodigital syndrome 9.6
914 bile duct cancer 9.6
915 extracutaneous mastocytoma 9.6
916 uremia 9.6
917 ganglioneuroma 9.6
918 sebaceous adenocarcinoma 9.6
919 benign ependymoma 9.6
920 epidermolysis bullosa dystrophica 9.6
921 neurotic disorder 9.6
922 pancreatitis 9.6
923 arteriolosclerosis 9.6
924 urinary tract obstruction 9.6
925 demyelinating polyneuropathy 9.6
926 pituitary gland disease 9.6
927 anterograde amnesia 9.6
928 sleep disorder 9.6
929 dystonia 9.6
930 syringocystadenoma papilliferum 9.6
931 cellular ependymoma 9.6
932 lice infestation 9.6
933 testicular germ cell cancer 9.6
934 malignant syringoma 9.6
935 kidney disease 9.6
936 eye disease 9.6
937 peripheral nervous system disease 9.6
938 acute stress disorder 9.6
939 adenoma 9.6
940 inverted follicular keratosis 9.6
941 premenstrual tension 9.6
942 muscular atrophy 9.6
943 gastrointestinal system disease 9.6
944 childhood leukemia 9.6
945 end stage renal disease 9.6
946 myocarditis 9.6
947 appendicitis 9.6
948 intestinal obstruction 9.6
949 influenza 9.6
950 arthritis 9.6
951 lung disease 9.6
952 fundus dystrophy 9.6
953 measles 9.6
954 chickenpox 9.6
955 decubitus ulcer 9.6
956 in situ carcinoma 9.6
957 intermediate coronary syndrome 9.6
958 actinic keratosis 9.6
959 skin melanoma 9.6
960 learning disability 9.6
961 waardenburg's syndrome 9.6
962 ocular hypertension 9.6
963 mechanical strabismus 9.6
964 exophthalmos 9.6
965 acute myocardial infarction 9.6
966 allergic asthma 9.6
967 fatty liver disease 9.6
968 meningitis 9.6
969 postpartum depression 9.6
970 neurofibroma 9.6
971 stomatitis 9.6
972 babesiosis 9.6
973 pathologic nystagmus 9.6
974 irritable bowel syndrome 9.6
975 esotropia 9.6
976 congenital syphilis 9.6
977 meibomian cyst 9.6
978 toxoplasmosis 9.6
979 hypoglycemia 9.6
980 myotonic dystrophy 9.6
981 atp6v0a2-related cutis laxa 9.6
982 ltbp4-related cutis laxa 9.6
983 mitochondrial disorders 9.6
984 acute graft versus host disease 9.6
985 adrenomyeloneuropathy 9.6
986 aminoaciduria 9.6
987 basaloid follicular hamartoma 9.6
988 binswanger's disease 9.6
989 bowen's disease 9.6
990 carcinoid syndrome 9.6
991 central congenital hypothyroidism 9.6
992 chromosomal triplication 9.6
993 cluster headache 9.6
994 craniofacial microsomia 9.6
995 encephalocele 9.6
996 enteropathica 9.6
997 eosinophilic pustular folliculitis 9.6
998 exfoliative dermatitis 9.6
999 germ cells tumors 9.6
1000 hemangioendothelioma 9.6
1001 hemimegalencephaly 9.6
1002 lewis-sumner syndrome 9.6
1003 lichen planus pemphigoides 9.6
1004 linear iga disease 9.6
1005 linear lichen planus 9.6
1006 lipoblastoma 9.6
1007 lymphangiectasis 9.6
1008 lymphomatoid papulosis 9.6
1009 neurosyphilis 9.6
1010 ovarian epithelial cancer 9.6
1011 papular mucinosis 9.6
1012 pityriasis lichenoides 9.6
1013 polymyositis 9.6
1014 primary cutaneous follicle center lymphoma 9.6
1015 pseudo-turner syndrome 9.6
1016 pseudobulbar affect 9.6
1017 pustular psoriasis 9.6
1018 ring chromosome 18 9.6
1019 ring chromosome 21 9.6
1020 rud syndrome 9.6
1021 soft tissue sarcoma 9.6
1022 sudden sensorineural hearing loss 9.6
1023 telangiectasia macularis eruptive perstans 9.6
1024 tièche-jadassohn nevus 9.6
1025 virilizing ovarian tumor 9.6
1026 isolated pierre robin sequence 9.6
1027 opioid addiction 9.6
1028 back pain 9.6
1029 cerebral arteriosclerosis 9.6
1030 chronic pain 9.6
1031 dysphagia 9.6
1032 febrile seizures 9.6
1033 hypotonia 9.6
1034 myoclonus 9.6
1035 pituitary tumors 9.6
1036 spasticity 9.6
1037 atopic keratoconjunctivitis 9.6
1038 subacute cutaneous lupus erythematosus 9.6
1039 cleft lip/palate 9.6
1040 monosomy 21 9.6
1041 inflammatory myopathy with abundant macrophages 9.6
1042 isolated split hand-split foot malformation 9.6
1043 autosomal dominant epidermolytic ichthyosis 9.6
1044 nevus of ota 9.6
1045 occipital encephalocele 9.6
1046 rare hereditary hemochromatosis 9.6
1047 pseudoxanthoma elasticum-like papillary dermal elastolysis 9.6
1048 scalp syndrome 9.6
1049 juvenile nasopharyngeal angiofibroma 9.6
1050 composite hemangioendothelioma 9.6
1051 neonatal lupus erythematosus 9.6
1052 erythema multiforme major 9.6
1053 oral erosive lichen 9.6
1054 bilateral acute depigmentation of the iris 9.6
1055 paraneoplastic pemphigus 9.6
1056 rhombencephalosynapsis 9.6
1057 inherited retinal disorder 9.6
1058 premature aging 9.6
1059 phakomatosis cesioflammea 9.6
1060 hepatosplenic t-cell lymphoma 9.6
1061 rare tumor 9.6
1062 primary hypophysitis 9.6
1063 cytophagic histiocytic panniculitis 9.6
1064 dermotrichic syndrome 9.6
1065 red cell aplasia 9.6
1066 malignant sertoli-leydig cell tumor of the ovary 9.6

Graphical network of the top 20 diseases related to Alopecia:



Diseases related to Alopecia

Symptoms & Phenotypes for Alopecia

UMLS symptoms related to Alopecia:


pruritus, exanthema

GenomeRNAi Phenotypes related to Alopecia according to GeneCards Suite gene sharing:

26 (showing 6, show less)
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Decreased viability GR00240-S-1 9.65 GJA1 SASH1
2 Decreased viability GR00249-S 9.65 LSS TP63
3 Decreased viability GR00381-A-1 9.65 LSS
4 Decreased viability GR00386-A-1 9.65 FOXN1 LSS VDR
5 Decreased viability GR00402-S-2 9.65 DSP EDNRA
6 Increased CFP-tsO45G cell surface transport GR00360-A-1 8.62 ANTXR1 GJA1

MGI Mouse Phenotypes related to Alopecia:

45 (showing 17, show less)
# Description MGI Source Accession Score Top Affiliating Genes
1 cardiovascular system MP:0005385 10.35 ANTXR1 AR AUTS2 DSP EDNRA FOXN1
2 cellular MP:0005384 10.34 ANTXR1 AR AUTS2 DCAF17 DSP EDNRA
3 growth/size/body region MP:0005378 10.34 AHSG AIRE ANTXR1 AR AUTS2 DSP
4 endocrine/exocrine gland MP:0005379 10.25 AIRE ANTXR1 AR AUTS2 EDNRA FOXN1
5 mortality/aging MP:0010768 10.21 AIRE ANTXR1 AR AUTS2 DSP EDNRA
6 craniofacial MP:0005382 10.2 ANTXR1 AR DSP EDNRA GJA1 HR
7 embryo MP:0005380 10.18 AR AUTS2 DSP EDNRA FOXN1 GJA1
8 immune system MP:0005387 10.17 AIRE ANTXR1 AR EDNRA FOXN1 GJA1
9 hematopoietic system MP:0005397 10.16 AIRE AR EDNRA FOXN1 GJA1 HR
10 digestive/alimentary MP:0005381 10.14 AIRE AR DSP EDNRA HR KRT14
11 integument MP:0010771 10.1 AR DSP EDNRA FOXN1 GJA1 HR
12 hearing/vestibular/ear MP:0005377 10.02 AHSG EDNRA FOXN1 GJA1 HR KRT14
13 muscle MP:0005369 9.92 AHSG AR DSP EDNRA FOXN1 GJA1
14 neoplasm MP:0002006 9.86 AIRE ANTXR1 AR AUTS2 FOXN1 HR
15 reproductive system MP:0005389 9.85 AIRE ANTXR1 AR DCAF17 FOXN1 GJA1
16 skeleton MP:0005390 9.65 AHSG ANTXR1 AR AUTS2 EDNRA FOXN1
17 vision/eye MP:0005391 9.23 AIRE EDNRA FOXN1 GJA1 HR KRT14

Drugs & Therapeutics for Alopecia

Drugs for Alopecia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(showing 406, show less)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Acitretin Approved Phase 4 55079-83-9, 69427-46-9 6437841
2
Hydroxychloroquine Approved Phase 4 118-42-3 3652
3
Imiquimod Approved, Investigational Phase 4 99011-02-6 57469
4
Latanoprost Approved, Investigational Phase 4 130209-82-4 5311221 5282380
5
Prednisolone phosphate Approved, Vet_approved Phase 4 302-25-0
6
Methylprednisolone Approved, Vet_approved Phase 4 83-43-2 6741
7
Methylprednisolone hemisuccinate Approved Phase 4 2921-57-5
8 Orange Approved Phase 4
9
Prednisolone Approved, Vet_approved Phase 4 50-24-8 5755
10 Prednisolone acetate Approved, Vet_approved Phase 4 52-21-1
11
Estradiol Approved, Investigational, Vet_approved Phase 4 50-28-2 5757
12
Polyestradiol phosphate Approved Phase 4 28014-46-2
13
Drospirenone Approved Phase 4 67392-87-4 68873
14
Ethinyl Estradiol Approved Phase 4 57-63-6 5991
15
Phylloquinone Approved, Investigational Phase 4 84-80-0
16 fluindione Approved, Investigational Phase 4 957-56-2
17
Warfarin Approved Phase 4 81-81-2 6691 54678486
18
Dalteparin Approved Phase 4 9005-49-6
19
Phenindione Approved, Investigational Phase 4 83-12-5 4760
20
Rivaroxaban Approved Phase 4 366789-02-8
21
Clobetasol Approved, Experimental, Investigational Phase 4 25122-41-2, 25122-46-7 32798 5311051
22
Betamethasone Approved, Vet_approved Phase 4 378-44-9 9782
23
Doxycycline Approved, Investigational, Vet_approved Phase 4 564-25-0 54671203
24
Fluocinonide Approved, Investigational Phase 4 356-12-7 9642
25
Apremilast Approved, Investigational Phase 4 608141-41-9 11561674
26
Acetylcysteine Approved, Investigational Phase 4 616-91-1 12035
27
Lidocaine Approved, Vet_approved Phase 4 137-58-6 3676
28
Cisplatin Approved Phase 4 15663-27-1 2767 441203 84093
29
Gemcitabine Approved Phase 4 95058-81-4 60750
30
Dexamethasone acetate Approved, Investigational, Vet_approved Phase 4 1177-87-3
31
Dexamethasone Approved, Investigational, Vet_approved Phase 4 50-02-2 5743
32
Histamine Approved, Investigational Phase 4 51-45-6 774
33
Cetirizine Approved Phase 4 83881-51-0 2678
34
Sotalol Approved Phase 4 3930-20-9, 959-24-0 5253
35
Triamcinolone Approved, Vet_approved Phase 4 124-94-7 31307
36
Menadione Approved, Nutraceutical Phase 4 58-27-5 4055
37
Cysteine Approved, Nutraceutical Phase 4 52-90-4 5862
38
Prednisolone hemisuccinate Experimental Phase 4 2920-86-7
39 Menaquinone Investigational Phase 4 1182-68-9
40 Keratolytic Agents Phase 4
41 Vitamins Phase 4
42 Antiprotozoal Agents Phase 4
43 Antimalarials Phase 4
44
protease inhibitors Phase 4
45 HIV Protease Inhibitors Phase 4
46 Anti-Infective Agents, Local Phase 4
47 Neuroprotective Agents Phase 4
48 Methylprednisolone Acetate Phase 4
49 Insulin, Globin Zinc Phase 4
50 insulin Phase 4
51 Estradiol 17 beta-cypionate Phase 4
52 Estradiol 3-benzoate Phase 4
53 Drospirenone and ethinyl estradiol combination Phase 4
54 Fenugreek Phase 4
55 Fenugreek seed meal Phase 4
56 Antithrombins Phase 4
57 Antithrombin III Phase 4
58 Serine Proteinase Inhibitors Phase 4
59 Factor Xa Inhibitors Phase 4
60 Heparin, Low-Molecular-Weight Phase 4
61 Antivitamins K Phase 4
62 Anticoagulants Phase 4
63 Vitamin K Phase 4
64 naphthoquinone Phase 4
65 Anti-Infective Agents Phase 4
66 Antiviral Agents Phase 4
67 Respiratory System Agents Phase 4
68 Anti-Asthmatic Agents Phase 4
69 Betamethasone sodium phosphate Phase 4
70 Betamethasone benzoate Phase 4
71 Betamethasone-17,21-dipropionate Phase 4
72 Betamethasone Valerate Phase 4 2152-44-5
73 Anesthetics Phase 4
74 Gastrointestinal Agents Phase 4
75 Antineoplastic Agents, Hormonal Phase 4
76 Antiemetics Phase 4
77 Antimetabolites Phase 4
78 N-monoacetylcystine Phase 4
79 Anesthetics, Local Phase 4
80 polysaccharide-K Phase 4
81
asparaginase Phase 4
82 Neurotransmitter Agents Phase 4
83 Anti-Allergic Agents Phase 4
84 Adrenergic Agents Phase 4
85 Histamine Antagonists Phase 4
86 Histamine H1 Antagonists, Non-Sedating Phase 4
87 Histamine H1 Antagonists Phase 4
88
Histamine Phosphate Phase 4 51-74-1 65513
89 Sodium Channel Blockers Phase 4
90 Anti-Arrhythmia Agents Phase 4
91 Adrenergic Antagonists Phase 4
92 Sympatholytics Phase 4
93 Adrenergic beta-Antagonists Phase 4
94 glucocorticoids Phase 4
95 Triamcinolone diacetate Phase 4
96 triamcinolone acetonide Phase 4
97 Triamcinolone hexacetonide Phase 4
98
Serine Investigational, Nutraceutical Phase 4 56-45-1 5951
99
Tofacitinib Approved, Investigational Phase 3 477600-75-2
100
Acetylcholine Approved, Investigational Phase 2, Phase 3 51-84-3 187
101
Dutasteride Approved, Investigational Phase 3 164656-23-9 152945 6918296
102
Hydrocortisone Approved, Vet_approved Phase 3 50-23-7 5754